Herpes simplex: treatment today.
Past and current therapies for recurrent mucocutaneous herpes simplex infections are reviewed. At present, no topical or systemic therapy has been proved safe and effective in scientific double-blind studies. Recent treatment with flexible collodion is discussed.
D001500:BCG Vaccine / Q000627:therapeutic use; D003101:Collodion / Q000627:therapeutic use*; D004396:Coloring Agents / Q000627:therapeutic use; D006561:Herpes Simplex / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D012900:Smallpox Vaccine / Q000008:administration & dosage / Q000009:adverse effects
D001500:BCG Vaccine; D004396:Coloring Agents; D012900:Smallpox Vaccine; D007978:Levamisole; D003101:Collodion; D007065:Idoxuridine